Delamere addiction rehabilitation clinic has seen a four-fold increase in admissions for ketamine over the past six months, ...

Breakthrough research could make any IV drug able to be taken orally for a range of hard-to-treat cancers and other diseases, and redefine how medicines are designed, evaluated and delivered.

A research team led by scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) made a major breakthrough with the potential to turn IV drugs into oral ...

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

Cardiovascular diseases are the world's leading cause of death, and high blood pressure, or hypertension, affects more than 1 ...

A team at UC Davis has created a new drug called JRT that mimics LSD’s brain-healing effects without the hallucinogenic side ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Abstract: Investigating potential interactions between drugs and herbal medicines helps optimize combined treatment strategies and supports personalized and precision medicine. Deep learning-based ...

However, they have physiological and genetic similarities in common with humans, making them ideal models for investigating immune responses, metabolic diseases and drug interactions. This is in ...

It also addresses Paxlovid's major limitation: drug interaction-induced side effects. "Most people who are at high risk of COVID-induced complications already take medications for diseases like ...

Dr Basavaraj GS from Narayana Health City, Bengaluru, explained that the real-world potential of another antidiabetic drug, Semaglutide (popular as Ozempic), was about 5-8%. He expects Mounjaro to ...

Eli Lil­ly’s Alzheimer’s drug Kisun­la has failed to get sup­port from the Eu­ro­pean Med­i­cines Agency over se­ri­ous side ef­fects and three pa­tient deaths.